Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Orexin to Treat Nicotine Dependence

NCT03999099 is registered in ClinicalTrials.gov with Mclean Hospital as lead sponsor.

NCT NCT03999099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03999099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Orexin to Treat Nicotine Dependence
Lead sponsor
Mclean Hospital
Phase
Phase 1
Overall status
Completed
Start date
September 26, 2019
Completion date
July 31, 2023
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence